Recurrent Esophageal Cancer Completed Phase 1 / 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0028797 (Recurrent Esophageal Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01231399Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal CancerTreatment